SFCM
ASND icon

Seven Fleet Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Seven Fleet Capital Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.79M Buy
12,179
+6,509
+115% +$1.46M 0.88% 30
2025
Q4 		$1.21M Buy
+5,670
New +$1.17M 0.82% 21

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Seven Fleet Capital Management's ASND Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Ascendis Pharma A/S (ASND) stake by 115% in Q1 2026, buying an estimated $1.46M and bringing the position to 12,179 shares worth $2.79M. The position accounts for 0.88% of the portfolio, ranked #30.

Seven Fleet Capital Management first reported a position in ASND in Q4 2025 and has held it in 2 quarters since. 274 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Seven Fleet Capital Management held 12,179 shares of Ascendis Pharma A/S worth $2.79M as of Q1 2026.
  • Seven Fleet Capital Management bought 6,509 Ascendis Pharma A/S shares in Q1 2026, an estimated $1.46M.
  • Ascendis Pharma A/S made up 0.88% of Seven Fleet Capital Management's portfolio in Q1 2026, its #30 holding.
  • Seven Fleet Capital Management first reported a position in Ascendis Pharma A/S in Q4 2025 and has held it in 2 quarters since.
  • 274 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.